| 12318-2 |
Spironolactone |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Spironolactone [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12318-2 |
|
|
|
|
Both |
|
|
|
0 |
Spironolactone Ur Ql |
|
|
|
|
|
Aldactone; DRUG/TOXICOLOGY; Drugs; Novospiroton; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12319-0 |
Thioridazine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Thioridazine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12319-0 |
|
|
|
|
Both |
|
|
|
0 |
Thioridazine Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Mellaril; Novo-ridazine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sonapax; Thioridazine Hydrochloride; Thioril; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 1232-8 |
M little i super little a Ag |
PrThr |
RBC^BPU |
Pt |
Ord |
|
|
ACTIVE |
Mi sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1232-8 |
|
|
|
|
Observation |
|
|
|
0 |
Mi sup(a) Ag RBC BPU Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; Hematology; Heme; i; M (little i) (little a); Mi sup(a); Mi^a; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12320-8 |
Thiothixene |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Thiothixene [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12320-8 |
|
|
|
|
Both |
|
|
|
0 |
Thiothixene Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Navane; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12321-6 |
Trifluoperazine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Trifluoperazine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12321-6 |
|
|
|
|
Both |
|
|
|
0 |
TriFperazine Ur Ql |
|
|
|
|
|
Calmazine; DRUG/TOXICOLOGY; Drugs; Eskazine; Eskazinyl; Jatroneural; Modalina; Novoflurazine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Solazine; Stelazine; Terfluzine; Trifluoperaz; TriFperazine; Triftazin; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12322-4 |
Triflupromazine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Triflupromazine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12322-4 |
|
|
|
|
Both |
|
|
|
0 |
TriFpromazine Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sparine; TriFpromazine; UA; UR; Urn; Vesprin |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12323-2 |
Trimeprazine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Trimeprazine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12323-2 |
|
|
|
|
Both |
|
|
|
0 |
Trimeprazine Ur Ql |
|
|
|
|
|
Alimazine; Amisal; Apamezin; Benalgen; Coplexens; Crasin; DRUG/TOXICOLOGY; Drugs; Meparil; Nedeltran; Normain A; Ordinal; Palpex; Panectyl; Point in time; PR; Pramin; QL; Qual; Qualitative; Random; Repeltin; Screen; Spansule; Telmatin; Temaridin; Temaril; Theralen; Theralene; Trixin; Turysin; UA; UR; Urn; Vallergan; Variargil; Vetalen |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12324-0 |
hydrOXYzine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
hydrOXYzine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12324-0 |
|
|
|
|
Both |
|
|
|
0 |
hydrOXYzine Ur Ql |
|
|
|
|
|
Atarax; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Vistaril |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12325-7 |
Tetrahydrocortisone |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Tetrahydrocortisone [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12325-7 |
|
|
|
|
Both |
|
|
|
0 |
THcortisone Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; THcortisone; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12326-5 |
Diamorphine |
PrThr |
Unk sub |
Pt |
Ord |
|
|
ACTIVE |
Diamorphine [Presence] in Unknown substance |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12326-5 |
|
|
|
|
Both |
|
|
|
0 |
DAM Usub Ql |
|
|
|
|
|
Addiction; DAM; Diacetyl morphine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Unknown substance; Usub |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12327-3 |
Ketamine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Ketamine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12327-3 |
|
|
|
|
Both |
|
|
|
0 |
Ketamine Ur Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ketalar; Ketaset; Ketavet; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12328-1 |
Beta blockers |
Prid |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Beta blockers [Identifier] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12328-1 |
|
|
|
|
Both |
|
|
|
0 |
Beta Blockers Ur |
|
|
|
|
|
B; Beta antagonists; Beta blocker; Beta-Adrenergic Agonist; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; UA; UR; Urn |
2.19 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 12329-9 |
chlorproPAMIDE |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
chlorproPAMIDE [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12329-9 |
|
|
|
|
Both |
|
|
|
0 |
chlorproPAMIDE Ur Ql |
|
|
|
|
|
Diabinese; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 1233-6 |
M little i super little a Ag |
PrThr |
RBC^Donor |
Pt |
Ord |
|
|
ACTIVE |
Mi sup(a) Ag [Presence] on Red Blood Cells from Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1233-6 |
|
|
|
|
Observation |
|
|
|
0 |
Mi sup(a) Ag RBC Donr Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; Donr; Erythrocytes; Hematology; Heme; i; M (little i) (little a); Mi sup(a); Mi^a; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12330-7 |
Hypoglycemics.oral |
Prid |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Hypoglycemics.oral [Identifier] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12330-7 |
|
|
|
|
Both |
|
|
|
0 |
Oral Hypogly Ur |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Oral Hypogly; Point in time; Random; UA; UR; Urn |
2.19 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 12331-5 |
Phenethylamine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Phenethylamine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12331-5 |
|
|
|
|
Both |
|
|
|
0 |
Phenethylamine Ur Ql |
|
|
|
|
|
2-phenylethylamine; Benzene ethanamine; Beta-phenylethylamine; C8H11N; DRUG/TOXICOLOGY; Drugs; Ordinal; PEA; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12332-3 |
Antihistamines |
Prid |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Antihistamines [Identifier] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12332-3 |
|
|
|
|
Both |
|
|
|
0 |
Antihistamines Ur |
|
|
|
|
|
Antihistamine; Anti-histamine; Anti-histamines; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 12333-1 |
Butorphanol |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Butorphanol [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12333-1 |
|
|
|
|
Both |
|
|
|
0 |
Butorphanol Ur Ql |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Stadol; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12334-9 |
Para aminophenol |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Para aminophenol [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
12334-9 |
|
|
|
|
Both |
|
|
|
0 |
p-Aminophenol Ur-mCnc |
|
|
|
Y |
|
4-aminophenol; 4-hydroxyaniline; Aniline metabolite; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; p-Aminophenol; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0j-a |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 12335-6 |
Halothane |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Halothane [Presence] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12335-6 |
|
|
|
|
Both |
|
|
|
0 |
Hal Bld Ql |
|
|
|
|
|
Anestan; Blood; Bromochlorotrifluoroethane; C2HBrClF3; Chalothane; DRUG/TOXICOLOGY; Drugs; FC-123B1; Fluktan; Fluorothane; Fluothane; Freon 123B1; Halan; Halotan; Halsan; Narcotan; Narkotan; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rhodialothan; Screen; WB; Whole blood |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12336-4 |
hydrALAZINE |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
hydrALAZINE [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12336-4 |
|
|
|
|
Both |
|
|
|
0 |
hydrALAZINE SerPl Ql |
|
|
|
|
|
Apresoline; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12337-2 |
Dimethylsulfoxide |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Dimethylsulfoxide [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12337-2 |
|
|
|
|
Both |
|
|
|
0 |
DMSO SerPl Ql |
|
|
|
|
|
Dimethyl sulfoxide; DMSO; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12338-0 |
Pentachlorophenol |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Pentachlorophenol [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12338-0 |
|
|
|
|
Both |
|
|
|
0 |
Pentachlorophen SerPl Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; PCP; Penta; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 12339-8 |
Diquat |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Diquat [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12339-8 |
|
|
|
|
Both |
|
|
|
0 |
Diquat Ur Ql |
|
|
|
|
|
1,1'-Ethylene-2,2'-bipyridyllium dibromide; 6,7-Dihydrodipyridol(1,2-a:2',1-c)pyrazinedium dibromide; 9,10-Dihydro-8a-10a-diazoniaphenanthrene dibromide; Deiquat; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Reward; Screen; UA; UR; Urn |
2.56 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 1234-4 |
M little i super little a Ag |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
Mi sup(a) Ag [Presence] on Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1234-4 |
|
|
|
|
Both |
|
|
|
0 |
Mi sup(a) Ag RBC Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; i; M (little i) (little a); Mi sup(a); Mi^a; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
